Novo Nordisk CEO grilled by Congress over Ozempic, Wegovy prices in US
For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...
The Harvard Crimson17m
HMS Professor Wins Prestigious Lasker-DeBakey Award for Work on GLP-1
Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...
ABC 10 News33m
US Senator Bernie Sanders grills CEO of Novo Nordisk on drug costs
The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing ...
BioSpace33m
Lilly and Novo Spend Billions to Expand Obesity Pipelines Beyond GLP-1s
Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...